Letter to the Editor
High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area : Seroprevalence of SARS-CoV-2 in HIV patientsAuthor links open overlay panel Basma ABDI a ,
Aude Laetitia NDOADOUMGUE b ,
Siham DJEBARA c ,
Karen ZAFILAZA a ,
Romain PALICH c ,
Stéphane MAROT a ,
Luminata SCHNEIDER c ,
Marc WIRDEN a ,
Sophie SEANG c ,
Yasmine DUDOIT c ,
Elisa TEYSSOU a ,
Roland TUBIANA c ,
Cathia SOULIE a ,
Marc Antoine VALANTIN c ,
Christine KATLAMA c ,
Vincent CALVEZ a ,
Lambert ASSOUMOU b ,
Anne-Geneviève MARCELIN a ,
Valérie POURCHER c Show more
Highlights
• Higher SARS-CoV-2 seroprevalence in HIV patients in comparison to the general population in France.
• High SARS-CoV-2 seroprevalence in African sub-Saharan HIV patients.
• Active smoking is associated with a lower rate of SARS-CoV-2 antibodies.
Keywords SARS-CoV-2
COVID-19
Seroprevalence
HIV
Humoral immune response
Risk factors
Recommended articles
View Abstract © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
